Nanotechnology Now - News Story: Pro-Pharmaceuticals Reports First Quarter

Home > News > Pro-Pharmaceuticals Reports First Quarter

May 22nd, 2006

Pro-Pharmaceuticals Reports First Quarter

Abstract:
Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel nanotechnology carbohydrate therapeutic compounds, today reported its first quarter 2006 financial results, for the period ended March 31, 2006.

Source:
businesswire

Bookmark:

Related News Press

Announcements

Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025

Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025

Next-generation quantum communication October 3rd, 2025

"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021



Premium Products


	Only the news you want to read! Learn More



	Full-service, expert consulting Learn More




	The latest news from around the world, FREE